Gaois

Search direction

Search mode

Filter results

Collections

5 results in 4 documents

  1. #2013501

    MDMA (eacstais)

    MDMA (ecstasy)

    Commission Implementing Regulation (EU) 2021/581 of 9 April 2021 on the situational pictures of the European Border Surveillance System (EUROSUR)

  2. #2013761

    MDMA (eacstais): 5000 táibléad

    MDMA (ecstasy): 5000 tablets

    Commission Implementing Regulation (EU) 2021/581 of 9 April 2021 on the situational pictures of the European Border Surveillance System (EUROSUR)

  3. #2518421

    Úsáidtear MAMDPA chun 3,4-meitiléindé-ocsaifeinilprópán-2-ón (PMK) a tháirgeadh, agus is réamhtheachtaí é sin de chuid 3,4-meitiléindé-ocsaimeitilamfataimín (MDMA), rud a dtugtar “eacstais” air go coitianta.

    MAMDPA is used to produce 3,4-Methylenedioxyphenylpropan-2-one (PMK), which, in turn, is a precursor of 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ‘ecstasy’.

    Commission Delegated Regulation (EU) 2022/1518 of 29 March 2022 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance)

  4. #2712587

    Is réamhtheachtaí 3,4-meitiléindé-ocsaifeiniolprópán-2-ón (PMK) é gliciodáit eitile PMK, a úsáidtear, ina dhiaidh sin, chun 3,4-meitiléindé-ocsaimeitiolamfataimín (MDMA) a tháirgeadh, ar a dtugtar “eacstais” de ghnáth.

    PMK ethyl glycidate is a precursor of 3,4-Methylenedioxyphenylpropan-2-one (PMK), which, in turn, is used to produce 3,4-methylenedioxymethamphetamine (MDMA), commonly known as ‘ecstasy’.

    Commission Delegated Regulation (EU) 2023/196 of 25 November 2022 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance)

  5. #1846588

    Go gairid tar éis margadh inmheánach gan teorainn a chruthú, agus tar éis drugaí sintéiseacha amhail amfataimíní agus eacstais a theacht chun cinn agus a scaipeadh go tapa, ba léir go mbeadh teorainn le héifeachtacht na ngníomhaíochtaí náisiúnta agus gur ghá gníomhaíocht ón AE le leathadh substaintí díobhálacha a shrianadh.

    Soon after a borderless internal market was created, and following the emergence and rapid spread of synthetic drugs, such as amphetamines and ecstasy, it became clear that the effectiveness of national actions is limited and that EU action was necessary to contain the spread of harmful substances.

    Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on new psychoactive substances